Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/16041
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMackiewicz, Jacek-
dc.contributor.authorWysocki, P.-
dc.contributor.authorKarczewska-Dzionka, A.-
dc.contributor.authorKwiatkowska-Borowczyk, E.-
dc.contributor.authorKozlowska, A.-
dc.contributor.authorBURZYKOWSKI, Tomasz-
dc.contributor.authorRose-John, S.-
dc.contributor.authorWiznerowicz, M.-
dc.contributor.authorMackiewicz, Andrzej-
dc.date.accessioned2013-12-05T10:15:44Z-
dc.date.available2013-12-05T10:15:44Z-
dc.date.issued2013-
dc.identifier.citationEUROPEAN JOURNAL OF CANCER, 49, p. S870-S870-
dc.identifier.issn0959-8049-
dc.identifier.urihttp://hdl.handle.net/1942/16041-
dc.language.isoen-
dc.titleImmunotargeting melanoma stem cells with Hyper-IL6 modified whole cell therapeutic vaccine (AGI-101H) in patients with advanced melanoma - a joint analysis of two phase 2 studies-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateSEP 27-OCT 01, 2013-
local.bibliographicCitation.conferencename17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.epageS870-
dc.identifier.spageS870-
dc.identifier.volume49-
local.bibliographicCitation.jcatM-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000326843605352-
item.contributorMackiewicz, Jacek-
item.contributorWysocki, P.-
item.contributorKarczewska-Dzionka, A.-
item.contributorKwiatkowska-Borowczyk, E.-
item.contributorKozlowska, A.-
item.contributorBURZYKOWSKI, Tomasz-
item.contributorRose-John, S.-
item.contributorWiznerowicz, M.-
item.contributorMackiewicz, Andrzej-
item.accessRightsClosed Access-
item.fullcitationMackiewicz, Jacek; Wysocki, P.; Karczewska-Dzionka, A.; Kwiatkowska-Borowczyk, E.; Kozlowska, A.; BURZYKOWSKI, Tomasz; Rose-John, S.; Wiznerowicz, M. & Mackiewicz, Andrzej (2013) Immunotargeting melanoma stem cells with Hyper-IL6 modified whole cell therapeutic vaccine (AGI-101H) in patients with advanced melanoma - a joint analysis of two phase 2 studies. In: EUROPEAN JOURNAL OF CANCER, 49, p. S870-S870.-
item.fulltextNo Fulltext-
crisitem.journal.issn0959-8049-
crisitem.journal.eissn1879-0852-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.